UT MD Anderson — Houston, Texas

Public research footprint of UT MD Anderson, compiled from the ClinicalTrials.gov public registry.

586

Registered studies

204

Active

Recruiting now

261

Completed

121

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Advanced Malignant Solid Neoplasm · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Recurrent Ovarian Carcinoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06064097 — A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UT MD Anderson?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.